Telik and MabVax tie the reverse merger knot
May 12 2014, 17:12 ET
Development stage Telik (TELK -4.6%) and private cancer immunotherapy firm MabVax Therapeutics sign a definitive merger agreement. The transaction will be an all-stock reverse merger. The subsequent firm, MabVax Therapeutics...